ArticleAmerican journal of cancer research2025
Impacts of BRCA mutations and clinical factors on niraparib efficacy in patients with platinum-sensitive recurrent ovarian cancer: a retrospective study.
Zheyu Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.